Informed consent for clinical trials: In search of the 'best' method

Social Science and Medicine

Volumn 47, Issue 11, 1998, Pages 1825-1840

  Edwards, Sarah J L ^a   Lilford, Richard J ^a   Thornton, Jim ^b   Hewison, Jenny ^b  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Anxiety; Clinical trials; Informed consent; Patient understanding; Randomised controlled trial; Recruitment rate

Indexed keywords

ANXIETY; ARTICLE; CLINICAL RESEARCH; CLINICAL TRIAL; COMPREHENSION; INFORMED CONSENT; INTERPERSONAL COMMUNICATION; PATIENT COUNSELING; PATIENT EDUCATION; PATIENT RIGHT; RANDOMIZATION;

CLINICAL TRIALS; ETHICS, MEDICAL; HUMANS; INFORMED CONSENT;

EID: 0031759315     PISSN: 02779536     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0277-9536(98)00235-4     Document Type: Article

References (42)

1. Aaronson N. K., Visserpol E., Leenhouts G. H. M. W., Muller M. V., Vanderschot A. C. M., Vandam F. S. A. M., Keus R. B., Koning C. C. E., Huinink W. W. T. Telephone-based nursing and intervention improves the effectiveness of the informed consent process in cancer clinical trials. Journal of Clinical Oncology. 14(3):1996;984-996.
2. Bergler J. H., Pennington A. C., Metcalfe M., Freis E. D. Informed consent: how much does the patient understand? Clinical Pharmacology and Therapeutics. 27(4):1980;435-440.
3. Corbett, F., Oldham, J., Lilford, R. J. (1996) Offering patients entry in clilnical trials: the views of prospective participants. Journal of Medical Ethics 22, 227-231.
4. Dal-Re R. Clinical trial of drugs: a study of the influence of information on adverse reactions on obtaining of informed consent. Medicina Clinica. 96(15):1991;566-569. (in Spanish).
5. Daugherty C.et al. Perceptions of cancer patients and their physicians involved in phase 1 trials. Journal of Clinical Oncology. 13(5):1995;1062-1072.
6. Davis, S., Seay, J., Stone, J. et al., Final report of "Does knowing about clinical trials increase participation?", unpublished.
7. Davis S., Seay J., Stone J.et al. Does knowing about clinical trials increase participation? Proceedings of the American Society of Clinical Oncology. 9:1990;A232. Abstract.
8. DCCT Research Group Implementation of a multicomponent process to obtain informed consent in a diabetes control and complications trial. Controlled Clinical Trials. 10:1989;83-96.
9. DeLuca S. A.et al. Are we promoting true informed consent in cardiovascular clinical trials? Journal of Cardiovascular Nursing. 9(3):1995;54-61.
10. Epstein L. C., Lasagna L. Obtaining informed consent: form or substance. Archives of Internal Medicine. 123:1969;682-688.
11. Fetting J. H., Siminoff L. A., Piantodsi S.et al. Effect of patients' expectations of benefit with standard breast cancer adjuvant chemotherapy on participation in a randomized clinical trial: a clinical vignette study. Journal of Clinical Oncology. 8:1990;1476-1482.
12. Gallet M., Aupetit J. F., Servan E., Lestaevel M., Lopez M., Chassoux G. Informed consent, what information is left after a therapeutic trial? Archives des Maladies du Coeur et des Vaisseaux. 87(1):1994;39-45. (in French).
13. Gallo C., Perrone F., De Placido S., Giusti C. Informed vs randomized consent to clinical trials. Lancet. 346:1995;1060-1064.
14. Harrison K., Vlahov D., Jones K., Charron K., Clements M. L. Medical eligibility, comprehension of the consent process, and retention of injection drug users recruited for an HIV vaccine trial. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 10:1995;386-390.
15. Harth S. C., Thong Y. H. Parental perceptions and attitudes about informed consent in clinical research involving children. Social Science and Medicine. 40:1995;1573-1577.
16. Hassar M., Weintraub M. "Uninformed" consent and the wealthy volunteer: an analysis of patient volunteers in a clinical trial of a new anti-flammatory drug. Clinical Pharmacology and Therapeutics. 20(4):1976;379-386.
17. BHAT Research Group, Howard J. M., Demets D. How informed is informed consent? The BHAT experience. Controlled Clinical Trials. 2:1981;287-304.
18. Jensen A. B., Madsen B., Anderson P., Rose C. Information for cancer patients entering a clinical trial: evaluation of an information strategy. European Journal of Cancer. 29:1993;2235-2238.
19. Kiauka, S., Prescott, R. et al., Factors that limit the quantity, number and progress of randomised controlled trials. HTA Monograph forthcoming.
20. King, J. (1986) Informed consent: a review of the empirical evidence. (Review) Institute of Medical Ethics Bulletin, December.
21. Levene M., Wright I., Griffiths G. Is informed consent in neonatal randomized controlled trial ritual? Lancet. 347:1996;475.
22. Lilford R. J., Jackson J. C. Equipoise and the ethics of randomisation. Journal of the Royal Society of Medicine. 88:1995;552-559.
23. Llewellyn-Thomas H. A. Cancer-patients decision-making and trial entry preferences: the effects of framing information about short-term toxicity and long-term survival. Medical Decision Making. 15(1):1995;4-12.
24. Lynoe N.et al. Informed consent: study of the quality of information given to participants in a clinical trial. BMJ. 303:1991;610-613.
25. Marini, Sheard, Bridges An evaluation of informed consent with volunteer prisoner subjects. Yale Journal of Biology and Medicine. 427:1976;434.
26. Maslin A. A survey of the opinions on "informed consent" of women currently involved in clinical trials within a breast unit. European Journal of Cancer Care. 3(4):1994;153-162.
27. McLean P. D. The effect of informed consent on the acceptance of random treatment assignment in a clinical population. Behavior Therapy. 11:1980;129-132.
28. Meisel A., Roth L. Toward a informed discussion of informed consent: a review and critique of the empirical studies. Arizona Law Review. 25:1983;246-265. Review.
29. Miller C., Searight H. R., Grable D., Schwartz R., Sowell C., Barbarash R. A. Comprehension and recall of the informational content of the informed consent document: an evaluation of 168 patients in a controlled clinical trial. Journal of Clinical Research and Drug Development. 8:1994;237-248.
30. Myers M. G., Cairns J. A., Singer J. The consent form as a possible cause of side-effects. Clinical Pharmacology and Therapeutics. 42(3):1987;250-253.
31. Oddens B. J., Algra A., van Gijn J. How much information is retained by participants in clinical trials? Nederlands Tijdschrift voor Geneeskunde. 136:1992;2272-2276. (in Dutch).
32. Olver I. N., Buchanan L., Laidlaw C., Poulton G. The adequacy of consent forms for informing patients entering oncological clinical trials. Annals of Oncology. 6:1995;867-870.
33. Penman D. T., Holland J. C., Bahna G. F., Morrow G., Schmale A. H., Derogatis L. R., Carnrike C. L., Cherry R. Informed consent for investigational chemotherapy: patients' and physicians' perceptions. Journal of Clinical Oncology. 2:1984;849-855.
34. Postlethwaite R. J., Reynolds J. M., Wood A. J., Evans J. H., Lewis M. A. Recruiting patients to clinical trials: lessons from studies of growth hormone treatment in renal failure. Archives of Disease in Childhood. 73(1):1995;30-35.
35. Rodenhuis S.et al. Patient motivation and informed consent in a phase i study of anticancer agent. European Journal of Cancer Clinical Oncology. 20:1984;457-462.
36. Simel D. L., Feussner J. R. A randomized controlled trial comparing quantitative informed consent formats. Journal of Clinical Epidemiology. 44(8):1991;771-777.
37. Simes R. J., Tattersall M. H. N., Coates A. S., Raghaven D., Solomon H. J., Smartt H. Randomised comparison of procedures for obtaining informed consent in clinical trials of treatment of cancer. BMJ. 293:1986;1065-1068.
38. Siminoff L. A., Fetting J. H. Factors affecting treatment decisions for a life-threatening illness: the case of medical treatment of breast cancer. Social Science & Medicine. 32(7):1991;813-818.
39. Silva M. D., Sorrell J. M. Enhancing comprehension of information for informed consent: a review of empirical research. (Review). IRB Human Subjects Research. 10:1988;1-6.
40. Tindall B., Forde S., Ross M. W., Goldstein D., Barker S., Cooper D. A. Effects of two formats of informed consent on knowledge amongst persons with advanced HIV disease in a clinical trial of didanosine. Patient Education and Counselling. 24(3):1994;261-266.
41. Tomamichel M., Sessa C., Herzig S., de Jong J., Pagani O., Willems Y., Cavalli F. Informed consent for phase i studies: evaluation of quantity and quality of information provided to patients. Annals of Oncology. 6(4):1995;363-369.
42. White D. R., Muss H. B., Michielutte R., Cooper M. R., Jackson D. V., Richards F., Stuart J. J., Spurr C. L. Informed consent: patient information forms in chemotherapy trials. American Journal of Clinical Oncology. 7:1984;183-190.